Last reviewed · How we verify

NCT03986307

The Effect of Omega-3 Supplementation on Muscle Functioning, Inflammation and Muscle Signaling

Completed NA Last updated 14 June 2019
What this trial tests

NA trial testing Omega-3 polyunsaturated fatty acid supplementation in Aging in 23 participants. Completed in 25 May 2019.

Timeline
1 January 2019
Primary endpoint
25 May 2019
25 May 2019

Quick facts

Lead sponsorKU Leuven
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment23
Start date1 January 2019
Primary completion25 May 2019
Estimated completion25 May 2019
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

KU Leuven — full company profile →

Who can join

Adults 65 to 100, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Elderly are supplemented with either Omega-3 (3 x 1.1g per day) or placebo (corn oil) during 14 weeks. The last 12 weeks, supplementation is combined with resistance exercise training (3x per week) focusing on upper leg strength. In the present project, the investigators study whether differences in muscle strength and/or muscle mass between conditions can be explained by omega-3-induced effects on systemic or muscle inflammatory signaling, or differences in muscle molecular signaling.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other KU Leuven trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03986307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing